Table of Contents
ISRN Endocrinology
Volume 2013, Article ID 723432, 8 pages
http://dx.doi.org/10.1155/2013/723432
Clinical Study

Clinicopathological Features of Growth Hormone-Producing Pituitary Adenomas in 242 Acromegaly Patients: Classification according to Hormone Production and Cytokeratin Distribution

1Department of Neurosurgery, The Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-ku, Tokyo 105-8461, Japan
2Department of Pathology, Toranomon Hospital, 2-2-2 Tranomon, Minato-ku, Tokyo 105-8470, Japan
3Division of Neuropathology, The Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-ku, Tokyo 105-8461, Japan
4Division of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo 105-8470, Japan
5Okinaka Memorial Institute for Medical Research, 2-2-2 Tranomon, Minato-ku, Tokyo 105-8470, Japan

Received 26 October 2012; Accepted 20 November 2012

Academic Editors: R. V. García-Mayor, S. La Rosa, and J. A. Rillema

Copyright © 2013 Ryosuke Mori et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Horvath and K. Kovacs, “Pathology of acromegaly,” Neuroendocrinology, vol. 83, no. 3-4, pp. 161–165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Y. Osamura, N. Egashira, H. Kajiya et al., “Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution,” Acta Histochemica et Cytochemica, vol. 42, no. 4, pp. 95–104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Adler, M. L. Waterman, X. He, and M. G. Rosenfeld, “Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain,” Cell, vol. 52, no. 5, pp. 685–695, 1988. View at Google Scholar · View at Scopus
  4. M. Bodner and M. Karin, “A pituitary-specific trans-acting factor can stimulate transcription from the growth hormone promoter in extracts of nonexpressing cells,” Cell, vol. 50, no. 2, pp. 267–275, 1987. View at Google Scholar · View at Scopus
  5. T. Minematsu, S. Miyai, H. Kajiya et al., “Recent progress in studies of pituitary tumor pathogenesis,” Endocrine, vol. 28, no. 1, pp. 37–41, 2005. View at Google Scholar · View at Scopus
  6. I. Kobayashi, H. Oka, H. Naritaka, Y. Sato, K. Fujii, and T. Kameya, “Expression of Pit-1 and growth hormone-releasing hormone receptor mRNA in human pituitary adenomas: difference among functioning, silent, and other nonfunctioning adenomas,” Endocrine Pathology, vol. 13, no. 2, pp. 83–98, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Sanno, A. Teramoto, A. Matsuno, J. Itoh, S. Takekoshi, and R. Y. Osamura, “In situ hybridization analysis of Pit-1 mRNA and hormonal production in human pituitary adenomas,” Acta Neuropathologica, vol. 91, no. 3, pp. 263–268, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. M. B. Lopes, “Growth hormone-secreting adenomas: pathology and cell biology,” Neurosurgical focus, vol. 29, no. 4, p. E2, 2010. View at Google Scholar · View at Scopus
  9. S. L. Asa, Tumors of the Pituitary Gland, Third Series. Atlas of Tumor Pathology, Armed Forces Institute of Pathology, Washington, DC, USA, 1998.
  10. P. R. Mazal, T. Czech, R. Sedivy et al., “Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients,” Clinical Neuropathology, vol. 20, no. 4, pp. 163–171, 2001. View at Google Scholar · View at Scopus
  11. H. Bando, T. Sano, T. Ohshima et al., “Differences in pathological findings and growth hormone responses in patients with growth hormone-producing pituitary adenoma,” Endocrinologia Japonica, vol. 39, no. 4, pp. 355–363, 1992. View at Google Scholar · View at Scopus
  12. T. Sano, T. Ohshima, and S. Yamada, “Expression of glycoprotein hormones and intracytoplasmic distribution of cytokeratin in growth hormone-producing pituitary adenomas,” Pathology Research and Practice, vol. 187, no. 5, pp. 530–533, 1991. View at Google Scholar · View at Scopus
  13. S. Yamada, T. Aiba, T. Sano et al., “Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology,” Neurosurgery, vol. 33, no. 1, pp. 20–27, 1993. View at Google Scholar · View at Scopus
  14. P. E. Neumann, J. E. Goldman, D. S. Horoupian, and M. A. Hess, “Fibrous bodies in growth hormone-secreting adenomas contain cytokeratin filaments,” Archives of Pathology and Laboratory Medicine, vol. 109, no. 6, pp. 505–508, 1985. View at Google Scholar · View at Scopus
  15. M. Kasper, P. Stosiek, G. N. P. van Muijen, and R. Moll, “Cell type heterogeneity of intermediate filament expression in epithelia of the human pituitary gland,” Histochemistry, vol. 93, no. 1, pp. 93–103, 1989. View at Google Scholar · View at Scopus
  16. E. Horvath and K. Kovacs, “Morphogenesis and significance of fibrous bodies in human pituitary adenomas,” Virchows Archiv Abteilung B Cell Pathology, vol. 27, no. 1, pp. 69–78, 1978. View at Google Scholar · View at Scopus
  17. D. M. Toivola, G. Z. Tao, A. Habtezion, J. Liao, and M. B. Omary, “Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments,” Trends in Cell Biology, vol. 15, no. 11, pp. 608–617, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Lundin and F. Pedersen, “Volume of pituitary macroadenomas: assessment by MRI,” Journal of Computer Assisted Tomography, vol. 16, no. 4, pp. 519–528, 1992. View at Google Scholar · View at Scopus
  19. E. Knosp, E. Steiner, K. Kitz et al., “Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings,” Neurosurgery, vol. 33, no. 4, pp. 610–618, 1993. View at Google Scholar · View at Scopus
  20. A. Obari, T. Sano, K. Ohyama et al., “Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form,” Endocrine Pathology, vol. 19, no. 2, pp. 82–91, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Bakhtiar, H. Hirano, K. Arita et al., “Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae,” European Journal of Endocrinology, vol. 163, no. 4, pp. 531–539, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Kovacs, “Pathology of growth hormone excess,” Pathology Research and Practice, vol. 183, no. 5, pp. 565–568, 1988. View at Google Scholar · View at Scopus
  23. H. Nishioka, H. Ito, and A. Hirano, “Immunohistochemical demonstration of oncocytes in nongonadotrophic pituitary adenomas,” Virchows Archiv, vol. 435, no. 4, pp. 428–433, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Nishioka, J. Haraoka, and K. Akada, “Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas,” Clinical Endocrinology, vol. 59, no. 6, pp. 768–772, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Melmed, G. D. Braunstein, E. Horvath, C. Ezrin, and K. Kovacs, “Pathophysiology of acromegaly,” Endocrine Reviews, vol. 4, no. 3, pp. 271–290, 1983. View at Google Scholar · View at Scopus
  26. A. Yoneda, T. Sano, S. Yamada et al., “Pituitary adenomas that show a faint GH-immunoreactivity but lack fibrous body: Pit-1 adenoma with endocrinologically low activity,” Endocrine Pathology, vol. 21, no. 1, pp. 40–47, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Nishioka, J. Haraoka, K. Akada, and S. Azuma, “Gender-related differences in prolactin secretion in pituitary prolactinomas,” Neuroradiology, vol. 44, no. 5, pp. 407–410, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Nishioka, H. Ito, J. Haraoka, and A. Hirano, “Growth potential of female prolactinomas,” Surgical Neurology, vol. 55, no. 4, pp. 213–217, 2001. View at Publisher · View at Google Scholar · View at Scopus